Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Neuroservice proconvulsive (NS-PC) set: A new platform of electrophysiology-based assays to determine the proconvulsive potential of lead compounds.

Steidl E, Gleyzes M, Maddalena F, Debanne D, Buisson B.

J Pharmacol Toxicol Methods. 2018 Sep - Oct;99:106587. doi: 10.1016/j.vascn.2019.106587. Epub 2019 Jun 14.

PMID:
31207287
2.

Effects of mirogabalin, a novel ligand for the α₂δ subunit of voltage-gated calcium channels, on N-type calcium channel currents of rat dorsal root ganglion culture neurons.

Kitano Y, Wakimoto S, Tamura S, Kubota K, Domon Y, Arakawa N, Saito M, Sava B, Buisson B.

Pharmazie. 2019 Mar 1;74(3):147-149. doi: 10.1691/ph.2019.8833.

PMID:
30961679
3.

Mechanistic characterization of S 38093, a novel inverse agonist at histamine H3 receptors.

Sors A, Panayi F, Bert L, Favale D, Nosjean O, Audinot V, Arrang JM, Buisson B, Steidl E, Delbos JM, Huhtala T, Kontkanen O, Chollet AM, Casara P, Lestage P.

Eur J Pharmacol. 2017 May 15;803:11-23. doi: 10.1016/j.ejphar.2017.03.013. Epub 2017 Mar 21.

PMID:
28336400
4.

Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington's Disease Models.

Beaumont V, Zhong S, Lin H, Xu W, Bradaia A, Steidl E, Gleyzes M, Wadel K, Buisson B, Padovan-Neto FE, Chakroborty S, Ward KM, Harms JF, Beltran J, Kwan M, Ghavami A, Häggkvist J, Tóth M, Halldin C, Varrone A, Schaab C, Dybowski JN, Elschenbroich S, Lehtimäki K, Heikkinen T, Park L, Rosinski J, Mrzljak L, Lavery D, West AR, Schmidt CJ, Zaleska MM, Munoz-Sanjuan I.

Neuron. 2016 Dec 21;92(6):1220-1237. doi: 10.1016/j.neuron.2016.10.064. Epub 2016 Dec 1.

5.

MPX-004 and MPX-007: New Pharmacological Tools to Study the Physiology of NMDA Receptors Containing the GluN2A Subunit.

Volkmann RA, Fanger CM, Anderson DR, Sirivolu VR, Paschetto K, Gordon E, Virginio C, Gleyzes M, Buisson B, Steidl E, Mierau SB, Fagiolini M, Menniti FS.

PLoS One. 2016 Feb 1;11(2):e0148129. doi: 10.1371/journal.pone.0148129. eCollection 2016. Erratum in: PLoS One. 2016;11(3):e0151452.

6.

Easy-to-fabricate conducting polymer microelectrode arrays.

Sessolo M, Khodagholy D, Rivnay J, Maddalena F, Gleyzes M, Steidl E, Buisson B, Malliaras GG.

Adv Mater. 2013 Apr 18;25(15):2135-9. doi: 10.1002/adma.201204322. Epub 2013 Feb 18.

PMID:
23417987
7.

Myotonic dystrophy CTG expansion affects synaptic vesicle proteins, neurotransmission and mouse behaviour.

Hernández-Hernández O, Guiraud-Dogan C, Sicot G, Huguet A, Luilier S, Steidl E, Saenger S, Marciniak E, Obriot H, Chevarin C, Nicole A, Revillod L, Charizanis K, Lee KY, Suzuki Y, Kimura T, Matsuura T, Cisneros B, Swanson MS, Trovero F, Buisson B, Bizot JC, Hamon M, Humez S, Bassez G, Metzger F, Buée L, Munnich A, Sergeant N, Gourdon G, Gomes-Pereira M.

Brain. 2013 Mar;136(Pt 3):957-70. doi: 10.1093/brain/aws367. Epub 2013 Feb 11.

8.

Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease.

Heikkinen T, Lehtimäki K, Vartiainen N, Puoliväli J, Hendricks SJ, Glaser JR, Bradaia A, Wadel K, Touller C, Kontkanen O, Yrjänheikki JM, Buisson B, Howland D, Beaumont V, Munoz-Sanjuan I, Park LC.

PLoS One. 2012;7(12):e50717. doi: 10.1371/journal.pone.0050717. Epub 2012 Dec 20.

9.

TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition.

Schaller S, Paradis S, Ngoh GA, Assaly R, Buisson B, Drouot C, Ostuni MA, Lacapere JJ, Bassissi F, Bordet T, Berdeaux A, Jones SP, Morin D, Pruss RM.

J Pharmacol Exp Ther. 2010 Jun;333(3):696-706. doi: 10.1124/jpet.110.167486. Epub 2010 Mar 9.

PMID:
20215409
10.

Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.

Bordet T, Buisson B, Michaud M, Abitbol JL, Marchand F, Grist J, Andriambeloson E, Malcangio M, Pruss RM.

J Pharmacol Exp Ther. 2008 Aug;326(2):623-32. doi: 10.1124/jpet.108.139410. Epub 2008 May 20.

PMID:
18492948
11.

Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis.

Bordet T, Buisson B, Michaud M, Drouot C, Galéa P, Delaage P, Akentieva NP, Evers AS, Covey DF, Ostuni MA, Lacapère JJ, Massaad C, Schumacher M, Steidl EM, Maux D, Delaage M, Henderson CE, Pruss RM.

J Pharmacol Exp Ther. 2007 Aug;322(2):709-20. Epub 2007 May 11.

PMID:
17496168
12.

The adult rat hippocampal slice revisited with multi-electrode arrays.

Steidl EM, Neveu E, Bertrand D, Buisson B.

Brain Res. 2006 Jun 22;1096(1):70-84. Epub 2006 May 23.

PMID:
16716268
13.

Allosteric modulation of ligand-gated ion channels.

Hogg RC, Buisson B, Bertrand D.

Biochem Pharmacol. 2005 Nov 1;70(9):1267-76.

PMID:
16043127
14.

Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism.

Vallejo YF, Buisson B, Bertrand D, Green WN.

J Neurosci. 2005 Jun 8;25(23):5563-72.

15.

Strategies for nicotine replacement therapy.

Buisson B.

Drug Discov Today. 2003 Sep 1;8(17):778-9. No abstract available.

PMID:
12946637
16.
17.

Expression of an alpha7 duplicate nicotinic acetylcholine receptor-related protein in human leukocytes.

Villiger Y, Szanto I, Jaconi S, Blanchet C, Buisson B, Krause KH, Bertrand D, Romand JA.

J Neuroimmunol. 2002 May;126(1-2):86-98.

PMID:
12020960
18.

Nicotine addiction: the possible role of functional upregulation.

Buisson B, Bertrand D.

Trends Pharmacol Sci. 2002 Mar;23(3):130-6. Review.

PMID:
11879680
19.

Potentiation of human alpha4beta2 neuronal nicotinic acetylcholine receptor by estradiol.

Curtis L, Buisson B, Bertrand S, Bertrand D.

Mol Pharmacol. 2002 Jan;61(1):127-35.

PMID:
11752213
20.

Neurotoxicity of channel mutations in heterologously expressed alpha7-nicotinic acetylcholine receptors.

Lukas RJ, Lucero L, Buisson B, Galzi JL, Puchacz E, Fryer JD, Changeux JP, Bertrand D.

Eur J Neurosci. 2001 May;13(10):1849-60.

PMID:
11403678
21.

A chronopharmacodynamic study on standard heparin, a low molecular weight heparin (nadroparin) and danaproid: establishing and comparing the daily variations of these drugs in rats.

Abrial D, Blanc A, Réhailia M, Mismetti P, Bouchut C, Laporte-Simitsidis S, Decousus H, Buisson B.

Haemostasis. 2000 Sep-Oct;30(5):233-42.

PMID:
11251330
22.
23.

The unusual nature of epibatidine responses at the alpha4beta2 nicotinic acetylcholine receptor.

Buisson B, Vallejo YF, Green WN, Bertrand D.

Neuropharmacology. 2000 Oct;39(13):2561-9.

PMID:
11044727
24.

Establishing the dose-dependent daily variations of a low molecular weight heparin (Fraxiparine) through a population approach analysis in the rat.

Abrial D, Blanc A, Réhailia M, Mismetti P, Bouchut C, Laporte-Simitsidis S, Decousus H, Buisson B.

Chronobiol Int. 2000 Mar;17(2):173-85.

PMID:
10757462
25.

Allosteric modulation of neuronal nicotinic acetylcholine receptors.

Buisson B, Bertrand D.

J Physiol Paris. 1998 Apr;92(2):89-100. Review.

PMID:
9782450
26.

Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor.

Buisson B, Bertrand D.

Mol Pharmacol. 1998 Mar;53(3):555-63.

PMID:
9495824
27.

Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor.

Krause RM, Buisson B, Bertrand S, Corringer PJ, Galzi JL, Changeux JP, Bertrand D.

Mol Pharmacol. 1998 Feb;53(2):283-94.

PMID:
9463487
28.

Paradoxical allosteric effects of competitive inhibitors on neuronal alpha7 nicotinic receptor mutants.

Bertrand S, Devillers-Thiéry A, Palma E, Buisson B, Edelstein SJ, Corringer PJ, Changeux JP, Bertrand D.

Neuroreport. 1997 Nov 10;8(16):3591-6.

PMID:
9427332
29.

[Comparison of daily alkaline phosphatase activity of a cyanobacterium (Microcystis aeruginosa) and a diatom (Synedra capitata)].

Giraudet H, Berthon JL, Buisson B.

C R Acad Sci III. 1997 Jun;320(6):451-8. French.

PMID:
9247024
30.

Low-affinity nerve growth factor receptor is associated with motoneuron axonal pathways.

Tanaka H, Tomura M, Kondo J, Teranishi Y, Buisson B, Xie FK, Henderson CE.

Neurosci Res. 1997 Jan;27(1):21-7.

PMID:
9089695
31.

Electrophysiology: a method to investigate the functional properties of ligand-gated channels.

Bertrand D, Buisson B, Krause RM, Hu HY, Bertrand S.

J Recept Signal Transduct Res. 1997 Jan-May;17(1-3):227-42.

PMID:
9029493
32.

Human alpha4beta2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: A patch-clamp study.

Buisson B, Gopalakrishnan M, Arneric SP, Sullivan JP, Bertrand D.

J Neurosci. 1996 Dec 15;16(24):7880-91.

33.

Stable expression and pharmacological properties of the human alpha 7 nicotinic acetylcholine receptor.

Gopalakrishnan M, Buisson B, Touma E, Giordano T, Campbell JE, Hu IC, Donnelly-Roberts D, Arneric SP, Bertrand D, Sullivan JP.

Eur J Pharmacol. 1995 Aug 15;290(3):237-46.

PMID:
7589218
34.

Survival of newly postmitotic motoneurons is transiently independent of exogenous trophic support.

Mettling C, Gouin A, Robinson M, el M'Hamdi H, Camu W, Bloch-Gallego E, Buisson B, Tanaka H, Davies AM, Henderson CE.

J Neurosci. 1995 Apr;15(4):3128-37.

35.

A G protein is involved in the angiotensin AT2 receptor inhibition of the T-type calcium current in non-differentiated NG108-15 cells.

Buisson B, Laflamme L, Bottari SP, de Gasparo M, Gallo-Payet N, Payet MD.

J Biol Chem. 1995 Jan 27;270(4):1670-4.

36.

[Screening for lead poisoning in children by measuring lead levels in housing: a study of the Paris region].

Ginot L, Peyr C, Fontaine A, Cheymol J, Buisson B, Bellia G, Da Cruz F, Buisson J.

Rev Epidemiol Sante Publique. 1995;43(5):477-84. French.

PMID:
7501895
37.
38.

The angiotensin AT2 receptor modulates T-type calcium current in non-differentiated NG108-15 cells.

Buisson B, Bottari SP, de Gasparo M, Gallo-Payet N, Payet MD.

FEBS Lett. 1992 Sep 7;309(2):161-4.

39.

Effect of Glutamate and Ionomycin on the Release of Arachidonic Acid, Prostaglandins and HETEs from Cultured Neurons and Astrocytes.

Oomagari K, Buisson B, Dumuis A, Bockaert J, Pin JP.

Eur J Neurosci. 1991;3(10):928-939.

PMID:
12106250
40.

[A simple device, using a microprocessor, to record the circadian locomotor activity of animals].

Benneton M, Rougny R, Vico L, Buisson B.

Med Biol Eng Comput. 1984 Jul;22(4):382-4. French. No abstract available.

PMID:
6748778
41.

[Rhythmic behavior of an isolated polyp of a colony of Veretillum cynomorium Pall. (Cnidaria Pennatularia)].

Buisson B.

C R Acad Hebd Seances Acad Sci D. 1973 Oct 15;277(15):1541-4. French. No abstract available.

PMID:
4149726
42.

RECIPROCAL BEHAVIOR OF THE RACHIS AND PEDUNCLE IN COLONIES OF VERETILLUM CYNOMORIUM PALL.

PAVANSDECECCATTY M, BUISSON B.

Am Zool. 1965 Aug;5:531-5. No abstract available.

PMID:
14345258
43.

[THE INTRAMESOGLEAN NERVOUS SYSTEM IN COLONIES OF VERETILLUM CYNOMORIUM PALL. (CNIDARIA, PENNATULIDAE)].

PAVANSDECECCATY M, BUISSON B.

C R Hebd Seances Acad Sci. 1964 Nov 16;259:3611-3. French. No abstract available.

PMID:
14231729

Supplemental Content

Loading ...
Support Center